Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7603167

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Consolidated statement of income
Statement of income
Net sales
105,534,000,000 JPY
102,904,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
25,000,000 JPY
49,000,000 JPY
Operating revenue
6,575,000,000 JPY
7,189,000,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
266,000,000 JPY
320,000,000 JPY
Rent expenses on land and buildings
310,000,000 JPY
312,000,000 JPY
Depreciation
243,000,000 JPY
223,000,000 JPY
Operating expenses
Selling, general and administrative expenses
44,433,000,000 JPY
45,841,000,000 JPY
Operating expenses
2,528,000,000 JPY
2,503,000,000 JPY
Operating expenses
Cost of sales
56,093,000,000 JPY
51,276,000,000 JPY
Net sales
Gross profit (loss)
49,441,000,000 JPY
51,627,000,000 JPY
Operating profit (loss)
5,007,000,000 JPY
4,046,000,000 JPY
5,786,000,000 JPY
4,685,000,000 JPY
Ordinary profit (loss)
5,569,000,000 JPY
3,960,000,000 JPY
6,447,000,000 JPY
4,585,000,000 JPY
Operating expenses
Research and development expenses
8,897,000,000 JPY
9,703,000,000 JPY
General and administrative expenses
Salaries
Cost of sales
Selling, general and administrative expenses
Advertising expenses
2,063,000,000 JPY
77,000,000 JPY
2,054,000,000 JPY
87,000,000 JPY
Non-operating income
Interest income
2,000,000 JPY
15,000,000 JPY
Dividend income
408,000,000 JPY
405,000,000 JPY
Other
105,000,000 JPY
113,000,000 JPY
Non-operating income
677,000,000 JPY
83,000,000 JPY
798,000,000 JPY
70,000,000 JPY
Extraordinary income
0 JPY
1,929,000,000 JPY
Non-operating expenses
Interest expenses
66,000,000 JPY
68,000,000 JPY
Other
44,000,000 JPY
56,000,000 JPY
Non-operating expenses
115,000,000 JPY
170,000,000 JPY
137,000,000 JPY
171,000,000 JPY
Extraordinary losses
352,000,000 JPY
0 JPY
25,000,000 JPY
0 JPY
Profit (loss) before income taxes
5,216,000,000 JPY
3,959,000,000 JPY
8,352,000,000 JPY
4,585,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
0 JPY
367,000,000 JPY
Gain on sale of investment securities
JPY
488,000,000 JPY
Income taxes - current
1,630,000,000 JPY
45,000,000 JPY
1,847,000,000 JPY
60,000,000 JPY
Extraordinary losses
Income taxes - deferred
-346,000,000 JPY
-5,000,000 JPY
374,000,000 JPY
8,000,000 JPY
Income taxes
1,284,000,000 JPY
40,000,000 JPY
2,222,000,000 JPY
68,000,000 JPY
Profit (loss)
3,919,000,000 JPY
3,919,000,000 JPY
3,919,000,000 JPY
3,932,000,000 JPY
3,919,000,000 JPY
4,516,000,000 JPY
4,516,000,000 JPY
6,130,000,000 JPY
4,516,000,000 JPY
4,516,000,000 JPY
Profit (loss) attributable to owners of parent
3,932,000,000 JPY
3,932,000,000 JPY
3,932,000,000 JPY
6,130,000,000 JPY
6,130,000,000 JPY
6,130,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
-393,000,000 JPY
-305,000,000 JPY
Foreign currency translation adjustment
151,000,000 JPY
-77,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
21,000,000 JPY
23,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-86,000,000 JPY
506,000,000 JPY
Other comprehensive income
-306,000,000 JPY
146,000,000 JPY
Comprehensive income
3,625,000,000 JPY
6,276,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
3,625,000,000 JPY
6,276,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.